Annovis Bio Inc. (ANVS) NEW YORK STOCK EXCHANGE INC.
$12.74 0.86 (7.24%)
Market Cap: $130.81M
As of 04/24/24 04:00 PM EDT. Market closed.
Annovis Bio Inc. (ANVS)
NEW YORK STOCK EXCHANGE INC.
$12.74
0.86 (7.24%)
Market Cap: $130.81M
As of 04/24/24 04:00 PM EDT. Market closed.
Add to Portfolio
annovis bio, inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. its lead compound is anvs401, which is in phase 2a clinical trials for the treatment of alzheimer's disease (ad), parkinson's disease, alzheimer's disease in down syndrome, and other chronic neurodegenerative disorders. the company is also developing anvs405 for protecting the brain after ... read more
COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Maria Maccecchini
Full Time Employees
8
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Maria Maccecchini
Full Time Employees
8
Address
1055 Westlakes Dr Ste 300, Pennsylvania, Berwyn, 19312-2410.
PRICE CHART FOR ANNOVIS BIO INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$12.05
Previous Close
$11.88
Days Range
$11.40 - $12.34
52 week range
$5.42 - $22.49
Volume
490,102
Avg. Volume (30 days)
194,816
Market Cap
$130.81M
Dividend Yield
-
P/E
-
Shares Outstanding
11,011,299
Open
$12.05
Previous Close
$11.88
Days Range
$11.40 - $12.34
52 week range
$5.42 - $22.49
Volume
490,102
Avg. Volume (30 days)
194,816
Market Cap
$130.81M
Dividend Yield
-
P/E
-
Shares Outstanding
11,011,299
FINANCIAL STATEMENTS FOR ANNOVIS BIO INC
LOADING...
INSIDER TRANSACTIONS FOR ANNOVIS BIO INC
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
White Mark K. | Director | Nov 20, 2023 | Option Exercise | $6.10 | 1,990 | 12,139 | 61,167 | Nov 22, 2023, 04:27 PM |
Hoffman Michael B | Director | Nov 20, 2023 | Option Exercise | $6.10 | 163,880 | 999,668 | 223,357 | Nov 22, 2023, 04:24 PM |
Maccecchini Maria-Luisa | President and CEO | Nov 20, 2023 | Option Exercise | $6.10 | 40,970 | 249,917 | 1,098,459 | Nov 22, 2023, 04:23 PM |
Hagopian Henry III | Chief Financial Officer | Nov 20, 2023 | Option Exercise | $6.10 | 820 | 5,002 | 1,820 | Nov 22, 2023, 04:21 PM |
McCarthy Reid | Director | Nov 20, 2023 | Option Exercise | $6.07 | 824 | 5,002 | 8,129 | Nov 21, 2023, 02:33 PM |
Hoffman Michael B | Director | Nov 20, 2023 | Option Exercise | $6.07 | 164,745 | 1,000,002 | 224,222 | Nov 21, 2023, 02:32 PM |
White Mark K. | Director | Nov 20, 2023 | Option Exercise | $6.07 | 2,000 | 12,140 | 61,177 | Nov 21, 2023, 02:31 PM |
Maccecchini Maria-Luisa | President and CEO | Nov 20, 2023 | Option Exercise | $6.07 | 41,186 | 249,999 | 1,098,675 | Nov 21, 2023, 02:30 PM |
Hagopian Henry III | Chief Financial Officer | Nov 20, 2023 | Option Exercise | $6.07 | 824 | 5,002 | 1,824 | Nov 21, 2023, 02:29 PM |
Bruck Claudine | Director | Nov 20, 2023 | Option Exercise | $6.07 | 1,000 | 6,070 | 7,567 | Nov 21, 2023, 02:27 PM |
White Mark K. | Director | Apr 07, 2023 | Option Exercise | $12.61 | 3,000 | 37,830 | 59,177 | Apr 11, 2023, 09:14 PM |
Bruck Claudine | Director | Apr 07, 2023 | Option Exercise | $12.61 | 500 | 6,305 | 6,567 | Apr 11, 2023, 09:11 PM |
Hagopian Henry III | Chief Financial Officer | Apr 07, 2023 | Option Exercise | $12.61 | 1,000 | 12,610 | 1,000 | Apr 11, 2023, 09:08 PM |
Hoffman Michael B | Director | Apr 07, 2023 | Option Exercise | $12.61 | 59,477 | 750,005 | 59,477 | Apr 11, 2023, 09:06 PM |
McCarthy Reid | Director | Apr 07, 2023 | Option Exercise | $12.61 | 476 | 6,002 | 7,305 | Apr 11, 2023, 09:05 PM |
Maccecchini Maria-Luisa | President and CEO | Apr 07, 2023 | Option Exercise | $12.61 | 20,000 | 252,200 | 1,060,489 | Apr 11, 2023, 09:03 PM |
Maccecchini Maria-Luisa | President and CEO | Feb 06, 2023 | Option Exercise | $0.14 | 52,755 | 7,386 | 1,040,489 | Feb 08, 2023, 05:11 PM |
Maccecchini Maria-Luisa | President and CEO | Jan 14, 2022 | Option Exercise | $0.14 | 32,959 | 4,614 | 987,734 | Jan 18, 2022, 09:08 PM |
Hoffman Michael B | Director | Jan 04, 2022 | Option Exercise | $19.78 | 6,748 | 133,475 | 1,416,283 | Jan 05, 2022, 07:41 PM |
Hoffman Michael B | Director | Jan 04, 2022 | Option Exercise | $3.59 | 37,142 | 133,485 | 1,416,373 | Jan 05, 2022, 07:41 PM |
Bruck Claudine | Director | Oct 11, 2021 | Buy | $27.66 | 181 | 5,006 | 6,067 | Oct 13, 2021, 04:03 PM |
White Mark K. | Director | Oct 12, 2021 | Buy | $27.40 | 5,000 | 137,000 | 56,177 | Oct 13, 2021, 04:02 PM |
Maccecchini Maria-Luisa | PRESIDENT AND CEO | Oct 11, 2021 | Buy | $27.61 | 18,000 | 496,980 | 976,775 | Oct 13, 2021, 04:00 PM |
McCarthy Reid | Director | Aug 19, 2021 | Buy | $37.61 | 500 | 18,805 | 6,829 | Aug 23, 2021, 11:36 AM |
Hoffman Michael B | Director | Jan 31, 2020 | Option Exercise | $4.80 | 55,884 | 268,243 | 1,400,175 | Feb 05, 2020, 06:05 AM |
Hoffman Michael B | Director | Jan 31, 2020 | Buy | $6.00 | 33,333 | 199,998 | 47,619 | Feb 05, 2020, 06:05 AM |
Whelan, Jr. Robert M. | Director | Jan 31, 2020 | Option Exercise | $4.80 | 11,176 | 53,645 | 95,700 | Feb 05, 2020, 06:05 AM |
Whelan, Jr. Robert M. | Director | Jan 31, 2020 | Buy | $6.00 | 25,000 | 150,000 | 25,000 | Feb 05, 2020, 06:05 AM |
Bruck Claudine | Director | Jan 31, 2020 | Option Exercise | $4.80 | 1,117 | 5,362 | 5,886 | Feb 05, 2020, 06:04 AM |
Bruck Claudine | Director | Jan 31, 2020 | Buy | $6.00 | 800 | 4,800 | 800 | Feb 05, 2020, 06:04 AM |
Maccecchini Maria-Luisa | President and CEO | Jan 31, 2020 | Buy | $6.00 | 1,600 | 9,600 | 207,942 | Feb 05, 2020, 06:03 AM |
McGroarty Jeffrey Brian | Chief Financial Officer | Feb 03, 2020 | Buy | $7.15 | 19,500 | 139,428 | 52,833 | Feb 05, 2020, 06:03 AM |
McGroarty Jeffrey Brian | Chief Financial Officer | Jan 31, 2020 | Buy | $6.00 | 33,333 | 199,998 | 33,333 | Feb 05, 2020, 06:03 AM |
White Mark K. | Director | Jan 31, 2020 | Option Exercise | $4.80 | 3,252 | 15,610 | 51,177 | Feb 05, 2020, 06:02 AM |
White Mark K. | Director | Jan 31, 2020 | Buy | $6.00 | 1,734 | 10,404 | 1,734 | Feb 05, 2020, 06:02 AM |
Load More Insider Transactions
Buy
Sale
Option Exercise
Load More Insider Transactions
FUNDS WITH A POSITION IN ANNOVIS BIO INC
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
ADAGE CAPITAL PARTNERS GP, L.L.C. | 285,347 | 0.01% | -4.88% | Other |
BLACKROCK INC. | 95,984 | 0.00005% | -0.31% | Other |
GEODE CAPITAL MANAGEMENT, LLC | 68,776 | 0.00013% | 22.73% | Other |
CHANGE IN SHARES OUTSTANDING FOR ANNOVIS BIO INC
STOCK BUYBACKS FOR ANNOVIS BIO INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 12/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2023
10.13%
1Q
06/30/2023
10.88%
2Q
03/31/2023
21.11%
3Q
12/31/2022
21.57%
4Q
09/30/2022
21.57%
5Q
06/30/2022
21.57%
6Q
03/31/2022
21.67%
7Q
12/31/2021
22.44%
8Q
09/30/2021
22.54%
9Q
06/30/2021
34.73%
10Q
03/31/2021
43.41%
11Q
12/31/2020
43.93%
12Q
09/30/2020
44.44%
13Q
06/30/2020
44.66%
14Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR ANNOVIS BIO INC
LOADING...